Sergio Traversa, CEO at RELMADA THERAPEUTICS, INC. (RLMD), sold 14,837 shares at $34.70 ($505K) on 2021-02-24, disclosed to the SEC on 2021-02-26.
Open-market sale of $505k RLMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.69 | 4,837 | $163K | 32.2% |
| 2 | $33.69 | 4,837 | $163K | 32.2% |
| 3 | $34.70 | 4,860 | $169K | 33.4% |
| 4 | $35.55 | 303 | $11K | 2.1% |
| Total | $34.06 avg | 14,837 | $505K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |